NCT05470244

Brief Summary

Total knee arthroplasty (TKA) is among the major advancements for the treatment of knee pain and improvement of physical function when conservative management fails to comply with. The success of this arthoplasty results in more functional mobility and better quality of life. However, management of pain after TKA in post-operative period is a big challenge to deal.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jul 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 12, 2022

Completed
1 day until next milestone

Study Start

First participant enrolled

July 13, 2022

Completed
9 days until next milestone

First Posted

Study publicly available on registry

July 22, 2022

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 15, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 15, 2022

Completed
Last Updated

April 7, 2023

Status Verified

April 1, 2023

Enrollment Period

5 months

First QC Date

July 12, 2022

Last Update Submit

April 5, 2023

Conditions

Keywords

Total Knee ArthoplastyKnee PainPost-operativeTranscutaneous electrical nerve stimulationIntra-venousAnalgesics requirementRecovery

Outcome Measures

Primary Outcomes (3)

  • Pain Intensity

    Pain intensity will be measured using Visual Analogue Scale

    Pain intensity will be measured at baseline,and change in pain intensity will be measured from baseline to 24 hour, 48 hour and 72 hours.

  • Rang of Motion

    Knee Rang of Motion will be measured using Universal Goniometer

    Knee Range of Motion will be measured at baseline, and Change in Knee Range of Motion will be measured from baseline to 24 hour, 48 hour and 72 hours

  • Intra-venous analgesic requirement

    Dose and frequency of intravenous analgesic requirement will be observed through Patient's file

    Analgesics requirement will be observed at first post-operative day, at second post-operative day, at third post-operative day

Secondary Outcomes (1)

  • Length of Hospital Stay

    It will be measured from the time of randomization till the time of discharge from hospital upto ten days

Study Arms (2)

Therapeutic Exercise Group

ACTIVE COMPARATOR

This group will receive Routine Physical therapy protocol along with prescribed intra-venous regimen.

Other: Routine Physical Therapy and Intra-venous analgesic regimen

TENS Plus Therapeutic Exercise Group

EXPERIMENTAL

This group will receive high frequency Transcutaneous Electrical Nerve Stimulation with routine physical therapy and prescribed intra-venous regimen.

Other: Transcutaneous Electrical Nerve Stimulation along with Routine Physical Therapy and Intra-venous analgesic regimen

Interventions

ROM Exercises will be performed and analgesics including the NSAIDs and narcotics as per prescription of surgeon/physician will be given to all subjects

Therapeutic Exercise Group

High frequency stimulations via Transcutaneous Electrical Nerve Simulator will be applied. ROM Exercises will be performed and analgesics including the NSAIDs and narcotics as per prescription of surgeon/physician will be given to all subjects

TENS Plus Therapeutic Exercise Group

Eligibility Criteria

Age31 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Both male and female
  • Aged between 31-70 years
  • Total Knee Arthoplasty, who had been diagnosed with knee osteoarthritis, inflammatory arthritis, trauma, fracture result in total knee arthoplasty.

You may not qualify if:

  • Any allergic condition of skin
  • Chronic consumption of opioids
  • History of dysplasia or malignancy to knee joint
  • Any major bone operation of lower limb
  • BMI higher than 35 kg m-2
  • History of mental disorder
  • Neurological illness e.g. Alzheimer which might interfere with assessment process.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The University of Lahore

Lahore, Punjab Province, 54000, Pakistan

Location

Study Officials

  • Prof. Dr. Ashfaq Ahmed, PhD

    University of Lahore

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
The outcome assessor will be unaware of the treatment group
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

July 12, 2022

First Posted

July 22, 2022

Study Start

July 13, 2022

Primary Completion

December 15, 2022

Study Completion

December 15, 2022

Last Updated

April 7, 2023

Record last verified: 2023-04

Data Sharing

IPD Sharing
Will share

it will be shared immediately after publication

Shared Documents
STUDY PROTOCOL
Time Frame
Beginning 9 months and ending on 36th month

Locations